key: cord-0886354-jzv376q5
authors: Connor, M.C.; Copeland, M.; Curran, T.
title: Investigation of saliva, tongue swabs and buccal swabs as alternative specimen types to nasopharyngeal swabs for SARS-CoV-2 testing
date: 2021-12-10
journal: J Clin Virol
DOI: 10.1016/j.jcv.2021.105053
sha: 56c912f1e48449f805a425d17ce39c4a50883b16
doc_id: 886354
cord_uid: jzv376q5

Throughout the ongoing SARS-CoV-2 pandemic, the recommended sample type for initial diagnostic testing for SARS-CoV-2 infection has been a nasopharyngeal swab. Shortages in swabs and difficulties in obtaining nasopharyngeal swabs in certain patient groups has prompted research into alternative specimen types for the diagnosis of COVID-19. The aim of this study was to assess how ‘simply collected’ saliva along with tongue swabs and buccal swabs preformed as an alternative specimen type for SARS-CoV-2 detection. It was observed that saliva samples allowed for the detection of 85.3% of positive patients, tongue swabs allowed for the detection of 67.6% of positive patients and buccal swabs allowed for detection of 20.8% of positive patients, when compared to nasopharyngeal swabs. From this data, it could be concluded that using simple saliva collection can provide a less invasive and reliable alternative method for the detection of SARS-CoV2 particularly in those patients where invasive sampling is difficult and where regular repeat testing is required.

Throughout the ongoing SARS-CoV-2 pandemic, the recommended sample type for initial diagnostic testing for SARS-CoV-2 infection has been a nasopharyngeal swab.

Shortages in swabs and difficulties in obtaining nasopharyngeal swabs in certain patient groups has prompted research into alternative specimen types for the diagnosis of COVID-19. The aim of this study was to assess how 'simply collected' saliva along with tongue swabs and buccal swabs preformed as an alternative specimen type for SARS-CoV-2 detection. It was observed that saliva samples allowed for the detection of 85.3% of positive patients, tongue swabs allowed for the detection of 67.6% of positive patients and buccal swabs allowed for detection of 20.8% of positive patients, when compared to nasopharyngeal swabs. From this data, it could be concluded that using simple saliva collection can provide a less invasive and reliable alternative method for the detection of SARS-CoV2 particularly 4 in those patients where invasive sampling is difficult and where regular repeat testing is required.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has been responsible for significant morbidity and mortality worldwide and is still currently having large impact on health care systems globally. The importance of fast turnaround of accurate and reliable results has been paramount for management of patients and implicating effective infection control measures, both in and out of the healthcare setting.

The sample type which is currently recommended for initial diagnostic testing for current SARS-CoV-2 infections is a nasopharyngeal swab (NPS) (1). NPS collection and testing remains the recommended testing standard as this sample type has been highlighted as providing the highest diagnostic sensitivity in early infection (2, 3) . The collection of NPS requires trained staff as incorrect sample collection will lead to inconsistent results (3) . Furthermore, collection of correctly taken NPS can be difficult to collect from certain patient groups, for example paediatric patients and patients with learning difficulties or dementia. 5 Shortages in swabs has prompted research into alternative specimen types for the diagnosis of COVID-19. Studies have reported mixed results on the usage of saliva as an appropriate sample for SARS-CoV-2 detection (4-6). However, previous studies suggest simply collecting saliva in a sterile container allows for successful detection of other respiratory viruses (7, 8) . The aim of this study was to assess how 'simply collected' saliva along with tongue swabs (TS) and buccal swabs (BS) performed as an alternative specimen type for SARS-CoV-2 detection. These sample types were selected for investigation due to the large number of angiotensin converting enzyme 2 (ACE-2) receptors found on the tongue and oral mucosa (9) .

Investigate saliva, TS and BS as an alternative specimen type for SARS-CoV-2 detection in comparison to the recommended sample type NPS.

NPS, saliva and TS were collected from 260 patients. Samples were collected from consenting patients who presented to the Emergency Department.

Subsequently, NPS, saliva, TS and BS were collected from patients of the previous cohort with known SARS-CoV-2 infection confirmed through RT-PCR. All patients had capacity and provided verbal consent to the collection of additional samples. 6 Samples were then processed and tested using the Allplex™ SARS-CoV-2 RT-PCR assay (Seegene, South Korea) to allow for comparison of Ct values. Specimens that returned a Ct 40> were regarded as negative.

NPS, saliva and TS from 260 patients were tested through PCR for the detection of SARS-CoV-2. Of these patients, 226 tested negative for SARS-CoV-2 and 34 patients tested positive. A comparison of the results retrieved across this different sample types from positive patients is displayed in Table 1 . Out of the positive patient cohort, 24 patients agreed to supply a buccal swab for comparison to other sample types. All sample types were taken at the same time to avoid variability. BS proved to be an inferior sample type detecting only 20.8% of positive patients (Table 1) . However, the Ct values obtained from TS were significantly higher than those obtained for NPS (p≤ 0.01; Figure 1 ). This further suggested TS are not an appropriate sample type for detecting SARS-CoV-2. 

The aim of this study was to assess how saliva, TS and BS preformed as an alternative It is important to note that another aim of this study was to test saliva as a suitable sample type, but to do so in a way that supply chain restrictions would not hinder the ability to collect samples. Therefore saliva samples were collected simply into sterile universal containers. This was important with the aim of avoiding supply chain restrictions that were observed with swabs during the 1st wave of the pandemic.

From this data, saliva represents a reliable and useful alternative sample for SAR-CoV2 testing particularly in the difficult patient groups outlined above. Saliva was in 100% concordance with NPS when calling negative results.

There are many variables affecting test results, for example, quality of samples in terms of timing and sample taking technique along with previous positivity of a patient and background prevalence. This provides a challenge to uniformity across studies evaluating different sample types. However from this data, using simple saliva collection can provide a less invasive and reliable alternative method for the detection of SARS-CoV2 particularly in those patients where invasive sampling is difficult and where regular repeat testing is required.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The work was performed as part of routine clinical laboratory operations.

Center of Disease Control and Prevention. 2021. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Viral load of SARS-CoV-2 in clinical samples

Clinical Samples for SARS-CoV-2 Detection: Review of the Early Literature

A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients

Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2. Clinical infectious diseases: ciaa1589

Saliva sample as a noninvasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study

Saliva as a 14 diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study

Additional molecular testing of saliva specimens improves the detection of respiratory viruses

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Virology, transmission, and pathogenesis of SARS-CoV-2